Decision Aid for Opioid Use Disorder

(PtDA-MAT Trial)

Recruiting in Palo Alto (17 mi)

Overseen by Larissa Mooney, M.D.

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: University of California, Los Angeles

No Placebo Group

Approved in 3 Jurisdictions

Trial Summary

What is the purpose of this trial?

The aim of the study is to test the effectiveness of the Patient Decision Aid for Opioid Use Disorder (PtDA-MAT) by conducting a stepped-wedge cluster-randomized trial in CA H\&SS (stratified by rural vs. non-rural areas) for adults with OUD. Patient outcomes will be tracked by (1) personal assessments (baseline, 3 months, and 6 months): drug use, overdose, healthcare utilization, and (2) clinical and administrative records (over approximately 24 months): drug treatment status and retention, physical and mental health diagnoses, arrest, incarceration, controlled substance use, and mortality. Multilevel models will be applied to test the intervention effects, controlling for possible temporal trends.

Eligibility Criteria

This trial is for adults with an Opioid Use Disorder diagnosis who agree to follow study procedures, including sharing their medical and other administrative records. The study will take place in CA H&SS and includes both rural and non-rural areas.

Inclusion Criteria

You have been diagnosed with opioid addiction and agree to follow study procedures, including sharing medical and administrative records.

Treatment Details

Interventions

• Patient Decision Aid (Behavioral Intervention)

Trial Overview The effectiveness of the Patient Decision Aid for Opioid Use Disorder (PtDA-MAT) is being tested through a stepped-wedge cluster-randomized trial. Outcomes like drug use, overdose, healthcare utilization, treatment status, mental health, arrests, substance use, and mortality will be tracked.

Participant Groups

Group I: Patient Decision Aid Experimental Treatment 1 Intervention

Participating clinics (and their patients) will be randomly selected to implement the intervention, at which time their patients will receive Patient Decision Aid for Medication Assisted Treatment for opioid use disorder.

Group II: Prior to intervention Active Control 1 Intervention

All participating clinics will start with a baseline period without the intervention. The clinics and their patients will remain in the no intervention condition until randomly selected to crossover to receive the intervention.

Patient Decision Aid is already approved in United States, European Union, Canada for the following indications:

🇺🇸 Approved in United States as Patient Decision Aid for:

• Supporting decision-making in medullary thyroid cancer care

🇪🇺 Approved in European Union as Patient Decision Aid for:

• Supporting decision-making in medullary thyroid cancer care

🇨🇦 Approved in Canada as Patient Decision Aid for:

• Supporting decision-making in medullary thyroid cancer care

Find a Clinic Near You

Research Locations Nearby Select from list below to view details:

UCLA Integrated Substance Abuse Programs Los Angeles, CA

Who Is Running the Clinical Trial?

University of California, Los Angeles Lead Sponsor

References